(Q77226445)
Statements
Neuraminidase treatment abrogates the binding abnormality of IgA1 from IgA nephropathy patients and the differential charge distribution of its alpha-heavy chains (English)
O H Hashim
A S Shuib
scientific article published on 01 December 2001